42 related articles for article (PubMed ID: 17403996)
1. Intracellular nucleotides of (-)-2',3'-deoxy-3'-thiacytidine in peripheral blood mononuclear cells of a patient infected with human immunodeficiency virus.
Solas C; Li YF; Xie MY; Sommadossi JP; Zhou XJ
Antimicrob Agents Chemother; 1998 Nov; 42(11):2989-95. PubMed ID: 9797238
[TBL] [Abstract][Full Text] [Related]
2. The reverse transcriptase inhibitor 3TC modulates hippocampal transcriptome signatures of inflammation in tauopathy model mice.
Wahl D; Grant RA; LaRocca TJ
Exp Gerontol; 2024 Jul; 192():112458. PubMed ID: 38735597
[TBL] [Abstract][Full Text] [Related]
3. Prospective analysis of tiopronin in prevention of sorafenib and antiviral therapy inducing liver toxicity in advanced hepatitis B virus-related hepatocellular carcinoma.
Li J; Qiu X; Guo W; Yan B; Zhang S
Med Oncol; 2015 Oct; 32(10):238. PubMed ID: 26330362
[TBL] [Abstract][Full Text] [Related]
4. SAMHD1 has differential impact on the efficacies of HIV nucleoside reverse transcriptase inhibitors.
Huber AD; Michailidis E; Schultz ML; Ong YT; Bloch N; Puray-Chavez MN; Leslie MD; Ji J; Lucas AD; Kirby KA; Landau NR; Sarafianos SG
Antimicrob Agents Chemother; 2014 Aug; 58(8):4915-9. PubMed ID: 24867973
[TBL] [Abstract][Full Text] [Related]
5. In silico study supports the efficacy of a reduced dose regimen for stavudine.
Hurwitz SJ; Schinazi RF
Antiviral Res; 2011 Nov; 92(2):372-7. PubMed ID: 21875620
[TBL] [Abstract][Full Text] [Related]
6. Selection and characterization of HIV-1 with a novel S68 deletion in reverse transcriptase.
Schinazi RF; Massud I; Rapp KL; Cristiano M; Detorio MA; Stanton RA; Bennett MA; Kierlin-Duncan M; Lennerstrand J; Nettles JH
Antimicrob Agents Chemother; 2011 May; 55(5):2054-60. PubMed ID: 21357304
[TBL] [Abstract][Full Text] [Related]
7. Antiretroviral therapy in macrophages: implication for HIV eradication.
Gavegnano C; Schinazi RF
Antivir Chem Chemother; 2009 Oct; 20(2):63-78. PubMed ID: 19843977
[TBL] [Abstract][Full Text] [Related]
8. Comparative analysis of in vitro processivity of HIV-1 reverse transcriptases containing mutations 65R, 74V, 184V and 65R+74V.
Sharma PL; Nettles JH; Feldman A; Rapp K; Schinazi RF
Antiviral Res; 2009 Sep; 83(3):317-23. PubMed ID: 19555722
[TBL] [Abstract][Full Text] [Related]
9. Cellular pharmacology of D-d4FC, a nucleoside analogue active against drug-resistant HIV.
Erickson-Viitanen S; Wu JT; Shi G; Unger S; King RW; Fish B; Klabe R; Geleziunas R; Gallagher K; Otto MJ; Schinazi RF
Antivir Chem Chemother; 2003 Jan; 14(1):39-47. PubMed ID: 12790515
[TBL] [Abstract][Full Text] [Related]
10. Antiviral and cellular metabolism interactions between Dexelvucitabine and lamivudine.
Hernandez-Santiago BI; Mathew JS; Rapp KL; Grier JP; Schinazi RF
Antimicrob Agents Chemother; 2007 Jun; 51(6):2130-5. PubMed ID: 17403996
[TBL] [Abstract][Full Text] [Related]
11. In vitro interactions between apricitabine and other deoxycytidine analogues.
Bethell R; De Muys J; Lippens J; Richard A; Hamelin B; Ren C; Collins P
Antimicrob Agents Chemother; 2007 Aug; 51(8):2948-53. PubMed ID: 17517847
[TBL] [Abstract][Full Text] [Related]
12. Perspectives on the molecular mechanism of inhibition and toxicity of nucleoside analogs that target HIV-1 reverse transcriptase.
Anderson KS
Biochim Biophys Acta; 2002 Jul; 1587(2-3):296-9. PubMed ID: 12084471
[TBL] [Abstract][Full Text] [Related]
13. Anti-hepatitis B virus activity and metabolism of 2',3'-dideoxy-2',3'-didehydro-beta-L(-)-5-fluorocytidine.
Zhu YL; Dutschman DE; Liu SH; Bridges EG; Cheng YC
Antimicrob Agents Chemother; 1998 Jul; 42(7):1805-10. PubMed ID: 9661025
[TBL] [Abstract][Full Text] [Related]
14. Metabolism of 2',3'-dideoxy-2',3'-didehydro-beta-L(-)-5-fluorocytidine and its activity in combination with clinically approved anti-human immunodeficiency virus beta-D(+) nucleoside analogs in vitro.
Dutschman GE; Bridges EG; Liu SH; Gullen E; Guo X; Kukhanova M; Cheng YC
Antimicrob Agents Chemother; 1998 Jul; 42(7):1799-804. PubMed ID: 9661024
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
